Literature DB >> 8972844

Multiplex Cre/lox recombination permits selective site-specific DNA targeting to both a natural and an engineered site in the yeast genome.

B Sauer1.   

Abstract

Variant lox sites having an altered spacer region (heterospecific lox sites) are not proficient for Cre-mediated recombination with the canonical 34 bp loxP site, but can recombine with each other. By placing different heterospecific lox sites at different genomic locations, Cre can catalyze independent DNA recombination events at multiple loci in the same cell without concern that unwanted inter-locus recombination events will be generated. Such heterospecific lox sites also allow Cre to specifically target efficient integration of exogenous DNA to endogenous lox-like sequences that naturally occur in the genome. Specific targeting occurs only with a DNA vector carrying a heterospecific lox site in which the spacer region has been redesigned to match the 'spacer' region of the targeted chromosomal element. Moreover, in cells expressing a catalytically active Cre recombinase, naturally occurring lox-like sequences can exhibit almost 20% mitotic recombination. Thus, in the same cell, heterospecific lox sites can be used independently at multiple loci for integration, for deletion and for enhanced mitotic recombination, thereby increasing the repertoire of genomic manipulations catalyzed by the Cre recombinase.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8972844      PMCID: PMC146311          DOI: 10.1093/nar/24.23.4608

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  27 in total

1.  Growth inhibition and DNA damage induced by Cre recombinase in mammalian cells.

Authors:  A Loonstra; M Vooijs; H B Beverloo; B A Allak; E van Drunen; R Kanaar; A Berns; J Jonkers
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-31       Impact factor: 11.205

Review 2.  Cre/lox: one more step in the taming of the genome.

Authors:  Brian Sauer
Journal:  Endocrine       Date:  2002-12       Impact factor: 3.633

3.  Site-specific genomic integration in mammalian cells mediated by phage phiC31 integrase.

Authors:  B Thyagarajan; E C Olivares; R P Hollis; D S Ginsburg; M P Calos
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

4.  Non-contact positions impose site selectivity on Cre recombinase.

Authors:  Andreas W Rüfer; Brian Sauer
Journal:  Nucleic Acids Res       Date:  2002-07-01       Impact factor: 16.971

Review 5.  Site-specific recombination for genetic engineering in plants.

Authors:  L A Lyznik; W J Gordon-Kamm; Y Tao
Journal:  Plant Cell Rep       Date:  2003-04-26       Impact factor: 4.570

6.  Site-specific integration of transgene targeting an endogenous lox-like site in early mouse embryos.

Authors:  Masanori Ito; Keitaro Yamanouchi; Kunihiko Naito; Michele P Calos; Hideaki Tojo
Journal:  J Appl Genet       Date:  2010-11-26       Impact factor: 3.240

7.  Segmental genomic replacement by Cre-mediated recombination: genotoxic stress activation of the p53 promoter in single-copy transformants.

Authors:  B Bethke; B Sauer
Journal:  Nucleic Acids Res       Date:  1997-07-15       Impact factor: 16.971

8.  Cre/lox-mediated site-specific integration of Agrobacterium T-DNA in Arabidopsis thaliana by transient expression of cre.

Authors:  A C Vergunst; P J Hooykaas
Journal:  Plant Mol Biol       Date:  1998-10       Impact factor: 4.076

9.  Evidence for baseline retinal pigment epithelium pathology in the Trp1-Cre mouse.

Authors:  Aristomenis Thanos; Yuki Morizane; Yusuke Murakami; Andrea Giani; Dimosthenis Mantopoulos; Maki Kayama; Mi In Roh; Norman Michaud; Basil Pawlyk; Michael Sandberg; Lucy H Young; Joan W Miller; Demetrios G Vavvas
Journal:  Am J Pathol       Date:  2012-03-17       Impact factor: 4.307

10.  A mouse model of Angelman syndrome imprinting defects.

Authors:  Michael W Lewis; Dorianmarie Vargas-Franco; Deborah A Morse; James L Resnick
Journal:  Hum Mol Genet       Date:  2019-01-15       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.